The world of tomorrow belongs to the proactive and creative mind.
Research is a primary focus at Wockhardt, with numerous initiatives targeting both identified market opportunities and the challenge of unmet medical needs. Addressing these goals, Wockhardt has a dedicated and infrastructurally sophisticated research complex, with 500 scientists,
150
of whom are PhDs. The Company’s investment in research over the past years has been significantly on the increase and is among the highest in the Indian pharmaceutical industry.
 |
| Our research teams focus on three major areas: |
|
|
Concentrated R&D efforts at Wockhardt have resulted in
750+
patent filings, including three in pharmaceutical biotechnology.
